AngioDynamics (NASDAQ:ANGO) reported fiscal 2026 third-quarter results that management described as “strong across the board, ...
Management raised FY2026 net sales guidance to $313.5 million to $315.5 million (from $312 million to $314 million) and raised adjusted EBITDA guidance to $10 million to $12 million (from $8 million ...
AngioDynamics, Inc. ( ANGO) Q3 2026 Earnings Call April 2, 2026 8:00 AM EDT Good morning, and welcome to the AngioDynamics Fiscal Year 2026 Third Quarter Earnings Call. [Operator Instructions] As a ...
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2026 Earnings Call Transcript April 2, 2026 AngioDynamics, Inc. misses on earnings ...
Georgia Urology is bringing a new prostate cancer treatment to the Northeast Georgia region. NanoKnife, the AngioDynamics system recognized by TIME as one of its Best Inventions of 2025, is a ...
From budget to Japanese-style models, here are chef Ben Lippett’s sharpest picks for comfort, cut and cost after weeks of chopping. Plus, what to know before you buy The kitchen gadgets top chefs ...
NanoKnife irreversible electroporation (IRE) uses pulses of electricity to create tiny holes within the membranes of prostate cancer cells, causing them to die. We typically place four needles around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results